21/61US=17 / Gastro
Varro A. Stromal cells and tumor microenvironment. In: Wang TC, Fox JG, Giraud AS. The biology of gastric cancers. New York: Springer, 2008. p. 587-600. ISBN 978-0-387-69181-7.

CELULAS DO ESTROMA; MICROAMBIENTE TUMORAL; CELULAS INFLAMATORIAS; FIBROBLASTOS; MIOFIBROBLASTOS

22/61US=28 / Biol/Mol
Lee S, Iruela-Arispe ML. The extracellular matrix and VEGF processing. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 85-97. ISBN 978-1-58829-870-6.

MATRIZ EXTRA-CELULAR; PROCESSAMENTO DE VEGF; METALOPROTEINASES DA MATRIZ; FACTORES DE CRESCIMENTO; ANGIOGENESE; MICROAMBIENTE TUMORAL; CELULAS ENDOTELIAIS; NEOVASCULARIZACAO

23/61US=35 / Biol/Mol
Littlepage LE, Egeblad M, Werb Z. The tumor microenvironment in cancer progression. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 229-39. ISBN 978-1-4160-3703-3.

MICROAMBIENTE DO TUMOR; PROGRESSAO DO CANCER; MACROFAGOS; FIBROBLASTOS; METALOPROTEINASES DA MATRIZ

24/61US=49-D / Câncer
Witz IP. Tumor-microenvironment interactions: dangerous liaisons. In: Woude GFV, Klein G. Advances in cancer research. v.100. Amsterdam: Elsevier, 2008. p. 203-29. ISBN 978-0-12-374358-9.

INTERACOES CELULAS TUMORAIS E MICROAMBIENTE; RESPOSTAS AO ESTRESSE; INTERACAO COM FIBROBLASTOS; INTERACAO TUMOR ENDOTELIO; INTERACAO TUMOR MACROFAGO; NICHO PRE-METASTATICO; INTERACAO TUMOR IMUNOGLOBULINA

25/61US=64 / Câncer
Raab MS, Anderson KC. Basic biology of plasma cell dyscrasias: focus on the role of the tumor microenvironment. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 23-39. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

BIOLOGIA BASICA DAS CELULAS PLASMATICAS DISCRASIAS; PAPEL DO MICROAMBIENTE TUMORAL

26/61US=65 / Biol/Mol
Moin K, Sameni M, Jedeszko C, Li Q, Olive MB, Mattingly RR, Sloane BF. Images of cleavage: tumor proteases in action. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 137-54. ISBN 978-0-387-69056-8.

IMAGENS DE CLIVAGEM; PROTEASES TUMORAIS; ATIVIDADE DE PROTEASES; IMAGEM INDIVIDUAIS; CLASSES DE PROTEASES; SUBSTRATOS SINTETICOS; IMAGIOLOGIA; ATIVIDADE PROTEOLITICA DE CELULAS VIVAS; IMAGEM DA ATIVIDADE PROTEOLITICA; INTERACOES DE CELULAS VIVAS; SISTEMAS MODELO; MICROAMBIENTE TUMORAL; IMAGIOLOGIA DE MODULACAO DA PROTEOLISE; ANALISE DA IMAGEM; METODOS DE PROCESSAMENTO DOS DADOS; QUANTIFICACAO DE PROTEOLISE

27/61US=65 / Biol/Mol
Mueller SC, Artym VV, Kelly T. Invadopodia: interface for invasion. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 403-31. ISBN 978-0-387-69056-8.

INVADOPODIA; COMPONENTES MOLECULARES; MEMBRANAS; ATIVIDADE PROTEOLITICA; ACTINA; CORTACTINA; NUCLEOS; PSEUDOPODIA; SALIENCIAS CELULARES EM 3D; INVADOPODIA DEGRADACAO MEDIADA; PROTEASES INVADOPODIAL; MICROAMBIENTE TUMORAL

28/61US=69 / Câncer
Zhou Y, Alexanian R, Wang M. Targeted therapy in multiple myeloma. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 213-36. ISBN 978-1-60327-423-4.

TERAPIA-ALVO; MIELOMA MULTIPLO; PATOGENESE MOLECULAR; MICROAMBIENTE

29/61US=84-A / Biol/Mol
Yasui H, Hideshima T, Anderson KC. Transformig growth factor-B in developing and advanced cancers: inhibition of TGF-B signaling in multiple myeloma and its bone marrow microenvironment. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 219-27. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; IL-6; VEGF; TGF-B RECEPTOR TIPO I; TBRI; MIELOMA MULTIPLO; MICROAMBIENTE DA MEDULA OSSEA; FATOR TRANSFORMADOR DE CRESCIMENTO; FACTOR DE CRESCIMENTO ENDOTELIAL VASCULAR; INIBIDOR DE QUINASE SD-208

30/61US=16 / Urologia
Assikis V. Therapeutics: co-targeting therapeutics for hormone refractory prostate cancer. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 463-73. (Contemporary Cancer Research) ISBN 978-1-58829-696-2.

CANCER DE PROSTATA; TERAPEUTICA; CO-SEGMENTACAO TERAPEUTICA; HORMONIO REFRATARIO; ANGIOGENESE; METASTASES OSSEAS; MICROAMBIENTE OSSEO; ESTROMA

31/61US=35 / Câncer
Mesa RA, Kaufmann SH. Molecular foundations of AML pathogenesis and physiology: altered apoptosis in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 133-61. ISBN 978-1-58829-621-4.

LEUCEMIA MIELOGENA AGUDA; APOPTOSE; RESISTENCIA MEDICAMENTOSA; BCL-2; MCL-1; XIAP; MICROAMBIENTE DA MEDULA OSSEA; RAS; FLT3

32/61US=20 / Biol/Mol
Lang SA, Stoeltzing O. Tumour models: analysis of angiogenesis in vivo. In: Staton CA, Lewis C, Bicknell R. Angiogenesis assays: a critical appraisal of current techniques. New Jersey: John Wiley & Sons, 2006. p. 265-91. ISBN 978-0-470-01600-8.

MODELOS DE TUMOR; ANALISE DA ANGIOGENESE IN VIVO; CAMUNDONGOS; MICROAMBIENTE TUMORAL; TIPOS DE TUMOR SUBCUTANEO; TIPOS DE TUMOR ORTOTOPICO; MODELOS DE RATOS TRANSGENICOS; ANGIOGENESE TUMORAL

33/61US=3 / Ginecologia
Smola-Hess S, Pfister H. Immune evasion in genital papillomavirus infection and cervical cancer: role of cytokines and chemokines. In: Campo MS. Papillomavirus research: from natural history to vaccines and beyong. Wymondham: Caister Academic Press, 2006. p. 321-39. ISBN 1-904455-04-2.

PAPILOMAVIRUS HUMANO; HPV; EVASAO IMUNE; PAPILOMAVIRUS GENITAL; CANCER CERVICAL; CITOCINAS; QUIMIOCINAS; MICROAMBIENTE DA MUCOSA; PROTEINA INFLAMATORIA MACROFAGICA-3ALFA; INTERLEUCINA-10; FATOR DE CRESCIMENTO TRANSFORMADOR-BETA; INTERLEUCINA-6; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; NECROSE TUMORAL-ALFA; TNF-ALFA; CD40

34/61US=61 / Câncer
Rak JW, Coomber B, Yu JL. Physiological resistance: oncogenes and tumor suppressor genes in therapeutic resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 67-103. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

ONCOGENES; GENES SUPRESSORES DE TUMORES; RESISTENCIA AS DROGAS; MICROAMBIENTE; INTERACOES TUMOR-HOSPEDEIRO

35/61US=61 / Câncer
Morin PJ. Biological resistance: the microenvironment and drug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 201-10. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

MICROAMBIENTE; MATRIZ EXTRACELULAR; CITOCINAS; FACTORES DE CRESCIMENTO; RESISTENCIA AS DROGAS; APOPTOSE; ANOIKIS

36/61US=61 / Câncer
Koh YT, García-Hernández ML, Kast WM. Clinical aspects of resistance: tumor immune escape mechanisms. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 577-602. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

IMUNOVIGILANCIA; IMUNOGENICIDADE; MECANISMOS DE ESCAPE; ANTIGENIOS TUMORAIS; IMUNODETECCAO; MICROAMBIENTE TUMORAL

37/61US=120 / Câncer
André MR, Silva BC, Dionísio MR, Lyden D. Metástase. In: Hoff PMG. Tratado de oncologia. São Paulo: Atheneu, 2013. p. 403-417. ISBN 85-388-0312-6.

TRANSICAO EPITELIAL MESENQUIMATOSA NO DESENVOLVIMENTO DO CANCER; REMODELAGEM DA MB; REMODELAGEM DA MEC; INTRAVASAMENTO. RESISTENCIA A APOPTOSE; EXTRAVASAMENTO E INVASAO SECUNDARIO; DETERMINANTES GENETICAS; REGULACAO MICROAMBIENTAL DE PROGRESSAO METASTATICA; MICROAMBIENTE NO LOCAL PRIMARIO; NICHO METASTATICO; LATENCIA DO TUMOR; METASTASE COM ALVO TERAPEUTICO

38/61US=22-C / Câncer
Hanahan D, Weinberg RA. Características de câncer: um princípio organizador para a oncologia. In: DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 10 ed. Philadelphia: Wolters Kluwer, 2015. p. 224-44. ISBN 978-1-45119294-0.

OITO CARACTERISTICA DO CANCER. SUSTENTAR SINALIZACAO PROLIFERATIVA; OITO CARACTERISTICA DO CANCER. EVITAR A DESTRUICAO IMUNE; OITO CARACTERISTICA DO CANCER. PERMITINDO A IMORTALIDADE REPLICATIVA; OITO CARACTERISTICA DO CANCER. ATIVACAO DE INVASAO E METASTASE; OITO CARACTERISTICA DO CANCER. INDUZIR A ANGIOGENESE; OITO CARACTERISTICA DO CANCER. RESISTINDO A MORTE CELULAR; OITO CARACTERISTICA DO CANCER. DESREGULAMENTACAO ENERGETICA CELULARES; OITO CARACTERISTICA DO CANCER. EVADIR SUPRESSORES DE CRESCIMENTO; SEGMENTACAO TERAPEUTICA DAS MARCAS DO CANCER; TIPOS DE CELULAS CONSTITUINTES DO MICROAMBIENTE TUMORAL

39/61US=22-C / Câncer
Marquardt JU, Thorgeirsson SS. Biologia molecular do câncer de fígado. In: DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 10 ed. Philadelphia: Wolters Kluwer, 2015. p. 690-695. ISBN 978-1-45119294-0.

ALTERACAO GENETICA EM CANCER DE FIGADO; ALTERACAO EPIGENETICA EM CANCER DE FIGADO; MICROAMBIENTE DO CANCER DE FIGADO; CARCINOMA HEPATOCELULAR. CLASSIFICACAO; CARCINOMA HEPATOCELULAR. PROGNOSTICO

40/61US=224 / Tese/FAP
Coló AEL. Perfil de expressão gênica em carcinoma epidermóide de cabeça e pescoço: alterações em módulos funcionais associadas à biologia e ao comportamento dos tumores. [Gene expression profile in head and neck squamous cell carcinoma: alterations in functional modules associated to tumor biology and behavior]. São Paulo, 2009. 107 p. Tese(Doutorado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/Doutorado/2009/AColo/AColo.pdf

Curriculum Lattes

EXPRESSAO GENICA; CARCINOMA EPIDERMOIDE; CANCER DE CABECA E PESCOCO; BIOLOGIA MOLECULAR; NEOPLASIAS. GENETICA

Primeira | Anterior | Próxima | Última